Shoulder Innovations, Inc. (NYSE: SI) Stock Competitors & Peer Comparison

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, ALC has a market cap of 34.1B. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while ALC trades at $70.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas ALC's P/E ratio is 22.21. In terms of profitability, SI's ROE is -0.26%, compared to ALC's ROE of +0.03%. Regarding short-term risk, SI is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for SI.Check ALC's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, STE has a market cap of 22.6B. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while STE trades at $232.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas STE's P/E ratio is 22.27. In terms of profitability, SI's ROE is -0.26%, compared to STE's ROE of +0.11%. Regarding short-term risk, SI is less volatile compared to STE. This indicates lower risk in terms of short-term price fluctuations for SI.Check STE's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, QDEL has a market cap of 923.7M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while QDEL trades at $13.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas QDEL's P/E ratio is 10.05. In terms of profitability, SI's ROE is -0.26%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, SI is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for SI.Check QDEL's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, MLAB has a market cap of 720.5M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while MLAB trades at $129.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas MLAB's P/E ratio is 12.99. In terms of profitability, SI's ROE is -0.26%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, SI is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for SI.Check MLAB's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, MASS has a market cap of 468.3M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while MASS trades at $11.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas MASS's P/E ratio is -18.88. In terms of profitability, SI's ROE is -0.26%, compared to MASS's ROE of -0.25%. Regarding short-term risk, SI is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for SI.Check MASS's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, BWAY has a market cap of 447.9M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while BWAY trades at $11.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas BWAY's P/E ratio is 29.01. In terms of profitability, SI's ROE is -0.26%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, SI is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for SI.Check BWAY's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, MOBI has a market cap of 352.9M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while MOBI trades at $10.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas MOBI's P/E ratio is -3.58. In terms of profitability, SI's ROE is -0.26%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, SI is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for SI.Check MOBI's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, ANIK has a market cap of 282.2M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while ANIK trades at $21.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas ANIK's P/E ratio is 43.04. In terms of profitability, SI's ROE is -0.26%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SI is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for SI.Check ANIK's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, LAB has a market cap of 249.5M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while LAB trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas LAB's P/E ratio is -9.08. In terms of profitability, SI's ROE is -0.26%, compared to LAB's ROE of -0.18%. Regarding short-term risk, SI is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for SI.Check LAB's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while EDAP trades at $4.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas EDAP's P/E ratio is -5.80. In terms of profitability, SI's ROE is -0.26%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, SI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for SI.Check EDAP's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, TRIB has a market cap of 160.2M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while TRIB trades at $7.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas TRIB's P/E ratio is -0.13. In terms of profitability, SI's ROE is -0.26%, compared to TRIB's ROE of +0.49%. Regarding short-term risk, SI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for SI.Check TRIB's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, APYX has a market cap of 100.7M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while APYX trades at $2.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas APYX's P/E ratio is -11.95. In terms of profitability, SI's ROE is -0.26%, compared to APYX's ROE of -0.79%. Regarding short-term risk, SI is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for SI.Check APYX's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, NYXH has a market cap of 83.2M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while NYXH trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas NYXH's P/E ratio is -0.32. In terms of profitability, SI's ROE is -0.26%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, SI is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for SI.Check NYXH's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, SKIN has a market cap of 73.6M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while SKIN trades at $11.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas SKIN's P/E ratio is -51.41. In terms of profitability, SI's ROE is -0.26%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, SI is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for SI.Check SKIN's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, MDAI has a market cap of 48.3M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while MDAI trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas MDAI's P/E ratio is -3.33. In terms of profitability, SI's ROE is -0.26%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, SI is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for SI.Check MDAI's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, DRIO has a market cap of 33.4M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while DRIO trades at $3.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas DRIO's P/E ratio is -0.58. In terms of profitability, SI's ROE is -0.26%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, SI is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for SI.Check DRIO's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, BEAT has a market cap of 22.5M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while BEAT trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas BEAT's P/E ratio is -0.78. In terms of profitability, SI's ROE is -0.26%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, SI is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for SI.Check BEAT's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, ITOC has a market cap of 22.1M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while ITOC trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas ITOC's P/E ratio is -0.77. In terms of profitability, SI's ROE is -0.26%, compared to ITOC's ROE of -0.60%. Regarding short-term risk, SI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for SI.Check ITOC's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, MDAIW has a market cap of 13.6M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while MDAIW trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas MDAIW's P/E ratio is -1.20. In terms of profitability, SI's ROE is -0.26%, compared to MDAIW's ROE of N/A. Regarding short-term risk, SI is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for SI.Check MDAIW's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, BEATW has a market cap of 8.3M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while BEATW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas BEATW's P/E ratio is -0.02. In terms of profitability, SI's ROE is -0.26%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, SI is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for SI.Check BEATW's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while QTEXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, SI's ROE is -0.26%, compared to QTEXW's ROE of N/A. Regarding short-term risk, SI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for SI.Check QTEXW's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, WOK has a market cap of 2.7M. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while WOK trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas WOK's P/E ratio is N/A. In terms of profitability, SI's ROE is -0.26%, compared to WOK's ROE of -0.19%. Regarding short-term risk, SI is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for SI.Check WOK's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, FEED has a market cap of 951.4K. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while FEED trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas FEED's P/E ratio is -0.15. In terms of profitability, SI's ROE is -0.26%, compared to FEED's ROE of -0.60%. Regarding short-term risk, SI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for SI.Check FEED's competition here

Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SI stands at 411.4M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, SI is priced at $19.75 on the NYSE, while TIVC trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SI currently has a P/E ratio of -11.42, whereas TIVC's P/E ratio is -0.04. In terms of profitability, SI's ROE is -0.26%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, SI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for SI.Check TIVC's competition here